Inventor · disambiguated record
David R. Tortolani
Also filed as: TORTOLANI DAVID R
18 granted patents·5 pending applications·910 citations·filing 1994–2022
95Inventor score
Top patents by PatentIndex Score
23 records- 0198US5792756AProdrugs of phosphonatesACAD OF SCIENCE CZECH REPUBLIC·Filed 1995·Granted Aug 11, 1998·244 cites·7 claims
- 0298US5663159AProdrugs of phosphonatesACAD OF SCIENCE CZECH REPUBLIC·Filed 1994·Granted Sep 2, 1997·336 cites·18 claims
- 0396US7723336B2Fused heterocyclic compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 25, 2010·50 cites·16 claims
- 0492US5559248ARetinoid-like heterocyclesBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Sep 24, 1996·93 cites·5 claims
- 0586US10660877B2Pyridyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 26, 2020·6 cites·18 claims
- 0685US11306092B2Amino indole compounds useful as TLR inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 19, 2022·3 cites·10 claims
- 0785US6995181B2Modulators of the glucocorticoid receptor and methodBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 7, 2006·23 cites·28 claims
- 0884US5523457ARetinoid-like compoundsBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Jun 4, 1996·61 cites·18 claims
- 0979US9492460B2Carbazole compounds useful as bromodomain inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 15, 2016·4 cites·15 claims
- 1078US10053454B2Carbazole compounds useful as bromodomain inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Aug 21, 2018·3 cites·5 claims
- 1177US5618839ARetinoid-like compoundsBRISTOL MYERS SQUIBB CO·Filed 1996·Granted Apr 8, 1997·37 cites·46 claims
- 1276US5648385ARetinoid-like compoundsBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Jul 15, 1997·36 cites·2 claims
- 1368US11739098B2Substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Aug 29, 2023·0 cites·12 claims
- 1468US6225324B1Antidepressant heterocyclic compoundsBRISTOL MYERS SQUIBB CO·Filed 1999·Granted May 1, 2001·11 cites·9 claims
- 1563US2025163104A1Macrocyclic immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1652US2021253593A1Substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 1749US12473290B2Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Nov 18, 2025·0 cites·3 claims
- 1849US2005171136A1Modulators of the glucocorticoid receptor and methodFiled 2005·Application pending·0 cites
- 1948US10196387B2Carbazole compounds useful as bromodomain inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 5, 2019·0 cites·5 claims
- 2048US7968577B2Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereofBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 28, 2011·0 cites·16 claims
- 2145US2007078136A1Fused heterocyclic compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
- 2243US2010204212A1Fused heterocyclic compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 2341US5849923AHeterocyclic-substituted naphthalenyl retinobenzoic acid derivativesBRISTOL MYERS SQUIBB CO·Filed 1996·Granted Dec 15, 1998·3 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when David R. Tortolani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →